文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

Miami Veterans Administration Medical Center, Miami, Florida, USA.

Curr Opin Allergy Clin Immunol. 2023 Oct 1;23(5):376-382. doi: 10.1097/ACI.0000000000000930. Epub 2023 Jul 17.

PURPOSE OF REVIEW

The purpose of this review is to provide an update on emerging literature on the role of the ocular surface microbiome (OSM) in allergic eye diseases.

RECENT FINDINGS

Findings in the literature suggest that the ocular surface microbiome plays a role in the pathophysiology and course of allergic disease of the ocular surface.

SUMMARY

Knowledge regarding the role of the ocular surface microbiome in allergic disease is important to guide development of targets for future therapeutic interventions.

目的综述

本篇综述的目的在于提供有关眼表微生物组（OSM）在过敏性眼病中作用的最新文献资料。

总结

了解眼表微生物组在过敏性疾病中的作用对于指导未来治疗干预靶点的开发很重要。

相似文献

Role of the ocular surface microbiome in allergic eye diseases.眼表微生物组在过敏性眼病中的作用。

Curr Opin Allergy Clin Immunol. 2023 Oct 1;23(5):376-382. doi: 10.1097/ACI.0000000000000930. Epub 2023 Jul 17.

Role of the ocular surface microbiome in allergic disease.眼表微生物组在过敏性疾病中的作用。

Curr Opin Allergy Clin Immunol. 2019 Oct;19(5):482-487. doi: 10.1097/ACI.0000000000000559.

Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.眼部炎症与过敏方面的近期专利及新兴疗法

Recent Pat Inflamm Allergy Drug Discov. 2017;11(2):92-106. doi: 10.2174/1872213X11666170913150146.

Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease.眼部用色甘酸钠。其在变应性眼病中治疗效果的概述。

Drugs. 1986 Feb;31(2):131-48. doi: 10.2165/00003495-198631020-00003.

Chemokines in allergic conjunctivitis.变应性结膜炎中的趋化因子

Curr Opin Allergy Clin Immunol. 2020 Oct;20(5):516-527. doi: 10.1097/ACI.0000000000000676.

Emerging drugs for ocular allergy.眼部过敏的新型药物

Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20. doi: 10.1517/14728214.10.3.505.

[Ocular allergies].[眼部过敏]

Ophthalmologe. 2005 May;102(5):527-43; quiz 544. doi: 10.1007/s00347-005-1181-y.

Allergic conjunctivitis: update on pathophysiology and prospects for future treatment.过敏性结膜炎：病理生理学最新进展及未来治疗前景

J Allergy Clin Immunol. 2005 Jan;115(1):118-22. doi: 10.1016/j.jaci.2004.10.042.

Characterization of ocular and nasopharyngeal microbiome in allergic rhinoconjunctivitis.变应性鼻结膜炎的眼和鼻咽微生物组特征。

Pediatr Allergy Immunol. 2019 Sep;30(6):624-631. doi: 10.1111/pai.13088. Epub 2019 Jul 25.

Ocular allergic disease in the senior patient: diagnosis and management.老年患者的眼部过敏性疾病：诊断与管理

Allergy Asthma Proc. 2000 Sep-Oct;21(5):277-83. doi: 10.2500/108854100778248250.

引用本文的文献

Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological Mechanisms.解读过敏性结膜炎：病因驱动因素及免疫病理机制的最新观点

Clin Rev Allergy Immunol. 2025 Aug 29;68(1):85. doi: 10.1007/s12016-025-09098-3.

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

Miami Veterans Administration Medical Center, Miami, Florida, USA.

Curr Opin Allergy Clin Immunol. 2023 Oct 1;23(5):376-382. doi: 10.1097/ACI.0000000000000930. Epub 2023 Jul 17.

PURPOSE OF REVIEW

The purpose of this review is to provide an update on emerging literature on the role of the ocular surface microbiome (OSM) in allergic eye diseases.

RECENT FINDINGS

Findings in the literature suggest that the ocular surface microbiome plays a role in the pathophysiology and course of allergic disease of the ocular surface.

SUMMARY

Knowledge regarding the role of the ocular surface microbiome in allergic disease is important to guide development of targets for future therapeutic interventions.